Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
Abstract Introduction Despite the ongoing efforts to refine treatment durations and methods for patients with chronic pulmonary aspergillosis, the clinical use of antifungal agents remains unclear. This study aimed to describe the treatment practices, trajectories, and prognoses of newly diagnosed p...
Saved in:
| Main Authors: | Takahiro Takazono, Yoshiyuki Saito, Masato Tashiro, Masataka Yoshida, Kazuaki Takeda, Shotaro Ide, Naoki Iwanaga, Naoki Hosogaya, Noriho Sakamoto, Hiroshi Mukae, Koichi Izumikawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-12-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-024-01094-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Observational study of the recent efficacy and economy of itraconazole vs. voriconazole in perioperative pulmonary aspergillosis
by: Peng Chen, et al.
Published: (2025-04-01) -
Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01) -
COVID-19-associated pulmonary aspergillosis: A lesson learned from COVID sequel
by: Priyanka Singh, et al.
Published: (2023-07-01) -
Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China
by: Zhuo Li, et al.
Published: (2025-05-01) -
Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis
by: Pinar Bakir Ekinci, et al.
Published: (2024-10-01)